Article info

Download PDFPDF
Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis

Authors

  • Taichi Sekine aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Tomohiro Kato aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kayo Masuko-Hongo aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Hiroshi Nakamura aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Shin-ichi Yoshino aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kusuki Nishioka aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kazuhiko Yamamoto aRheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, Kanagawa, Japan, bMitsubishi Kagaku Bio-Clinical Laboratories Inc, Tokyo, Japan, cDivision of Rheumatology, Nihon Medical School, Tokyo, Japan, dDivision of Allergy and Rheumatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  1. Dr T Kato, Rheumatology, Immunology and Genetics Program, Institute of Medical Science, St Marianna University School of Medicine, 2–16–1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216–8512, Japan.
View Full Text

Citation

Sekine T, Kato T, Masuko-Hongo K, et al
Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis

Publication history

  • Accepted February 23, 1999
  • First published July 1, 1999.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.